Wave Life Sciences Ltd.
Developing RNA-based medicines for severe genetic diseases like DMD and Huntington's disease.
WVE | US
Overview
Corporate Details
- ISIN(s):
- USY953081053 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 7 STRAITS VIEW, 18936 SINGAPORE
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Wave Life Sciences Ltd. is a clinical-stage biotechnology company dedicated to developing transformative RNA-based medicines for genetically defined diseases. The company leverages its proprietary PRISM® platform, which combines chemistry innovation and deep insights in human genetics, to create stereopure oligonucleotide therapeutics. Wave's pipeline focuses on advancing first- or best-in-class treatments for severe conditions with high unmet medical needs. Key therapeutic areas include Duchenne muscular dystrophy (DMD), Huntington's disease, Alpha-1 antitrypsin deficiency (AATD), and obesity. The company's mission is to deliver life-changing therapies for patients with both rare and common disorders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Wave Life Sciences Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Wave Life Sciences Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Wave Life Sciences Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
